Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 6—June 2005
Research

Community-associated Methicillin-resistant Staphylococcus aureus in Hospital Nursery and Maternity Units

Simona Bratu*, Antonella Eramo†, Robert Kopec‡, Elizabeth Coughlin‡, Monica Ghitan‡, Robert Yost‡, Edward K. Chapnick‡, David Landman*Comments to Author , and John Quale*
Author affiliations: *State University of New York-Downstate, Brooklyn, New York, USA; †Long Island College Hospital, Brooklyn, New York, USA; ‡Maimonides Medical Center, Brooklyn, New York, USA

Main Article

Table 2

Susceptibility data on Staphylococcus aureus isolates collected from 11 to 15 hospitals in 1999, 2001, and 2003*

1999 (N = 567) 2001 (N = 772) 2003 (N = 588)
% MRSA 36 46 52
Antimicrobial agent (% susceptible)
Azithromycin 14 5 5
Clindamycin 18 15 20
Vancomycin 100 100 100
Daptomycin ND 100 100
Tigecycline ND ND 100
Minocycline 98 ND 98
Linezolid 100 ND 100
Rifampin 88 92 95
Imipenem 37 49 56
Ciprofloxacin 10 8 7
Trimethoprim-sulfamethoxazole 75 80 89

*MRSA, methicillin-resistant Staphylococcus aureus; ND, not done.

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external